Global Oncology Immunotherapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Oncology Immunotherapy market size was valued at US$ 2202 million in 2023. With growing demand in downstream market, the Oncology Immunotherapy is forecast to a readjusted size of US$ 3915.2 million by 2030 with a CAGR of 8.6% during review period.
The research report highlights the growth potential of the global Oncology Immunotherapy market. Oncology Immunotherapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oncology Immunotherapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oncology Immunotherapy market.
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The Oncology Immunotherapy market has expanded as a groundbreaking approach to treating cancer by harnessing the body's immune system to target and fight cancer cells. This innovative therapy includes immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines, among others. By enhancing the immune response against tumors, immunotherapy offers potentially durable and targeted treatments, often with fewer side effects compared to traditional approaches. The market's growth is driven by promising clinical outcomes and a growing understanding of immune-tumor interactions. As researchers continue to explore and refine immunotherapeutic strategies, the Oncology Immunotherapy market remains at the forefront of oncology, revolutionizing cancer treatment paradigms and offering new hope to patients.
Key Features:
The report on Oncology Immunotherapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oncology Immunotherapy market. It may include historical data, market segmentation by Type (e.g., Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oncology Immunotherapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oncology Immunotherapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oncology Immunotherapy industry. This include advancements in Oncology Immunotherapy technology, Oncology Immunotherapy new entrants, Oncology Immunotherapy new investment, and other innovations that are shaping the future of Oncology Immunotherapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oncology Immunotherapy market. It includes factors influencing customer ' purchasing decisions, preferences for Oncology Immunotherapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oncology Immunotherapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oncology Immunotherapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oncology Immunotherapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oncology Immunotherapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oncology Immunotherapy market.
Market Segmentation:
Oncology Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Oncology Immunotherapy market size was valued at US$ 2202 million in 2023. With growing demand in downstream market, the Oncology Immunotherapy is forecast to a readjusted size of US$ 3915.2 million by 2030 with a CAGR of 8.6% during review period.
The research report highlights the growth potential of the global Oncology Immunotherapy market. Oncology Immunotherapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oncology Immunotherapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oncology Immunotherapy market.
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The Oncology Immunotherapy market has expanded as a groundbreaking approach to treating cancer by harnessing the body's immune system to target and fight cancer cells. This innovative therapy includes immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines, among others. By enhancing the immune response against tumors, immunotherapy offers potentially durable and targeted treatments, often with fewer side effects compared to traditional approaches. The market's growth is driven by promising clinical outcomes and a growing understanding of immune-tumor interactions. As researchers continue to explore and refine immunotherapeutic strategies, the Oncology Immunotherapy market remains at the forefront of oncology, revolutionizing cancer treatment paradigms and offering new hope to patients.
Key Features:
The report on Oncology Immunotherapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oncology Immunotherapy market. It may include historical data, market segmentation by Type (e.g., Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oncology Immunotherapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oncology Immunotherapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oncology Immunotherapy industry. This include advancements in Oncology Immunotherapy technology, Oncology Immunotherapy new entrants, Oncology Immunotherapy new investment, and other innovations that are shaping the future of Oncology Immunotherapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oncology Immunotherapy market. It includes factors influencing customer ' purchasing decisions, preferences for Oncology Immunotherapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oncology Immunotherapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oncology Immunotherapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oncology Immunotherapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oncology Immunotherapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oncology Immunotherapy market.
Market Segmentation:
Oncology Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Immune Checkpoint Inhibitors
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
- Other
- Hospitals
- Drugstores
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb
- Merck & Co
- Roche AG
- AstraZeneca
- Sanofi S.A.
- Dendreon Pharmaceuticals
- Novartis
- Gilead Sciences Inc.
- Merck KGaA
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Immunotherapy Market Size 2019-2030
2.1.2 Oncology Immunotherapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Oncology Immunotherapy Segment by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Cytokine-Based Immunotherapy
2.2.3 Cancer Vaccines
2.2.4 CAR-T Cell Therapy
2.2.5 Other
2.3 Oncology Immunotherapy Market Size by Type
2.3.1 Oncology Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
2.4 Oncology Immunotherapy Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.4.3 Others
2.5 Oncology Immunotherapy Market Size by Application
2.5.1 Oncology Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
3 ONCOLOGY IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 Oncology Immunotherapy Market Size Market Share by Players
3.1.1 Global Oncology Immunotherapy Revenue by Players (2019-2024)
3.1.2 Global Oncology Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY IMMUNOTHERAPY BY REGIONS
4.1 Oncology Immunotherapy Market Size by Regions (2019-2024)
4.2 Americas Oncology Immunotherapy Market Size Growth (2019-2024)
4.3 APAC Oncology Immunotherapy Market Size Growth (2019-2024)
4.4 Europe Oncology Immunotherapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Oncology Immunotherapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Oncology Immunotherapy Market Size by Country (2019-2024)
5.2 Americas Oncology Immunotherapy Market Size by Type (2019-2024)
5.3 Americas Oncology Immunotherapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Immunotherapy Market Size by Region (2019-2024)
6.2 APAC Oncology Immunotherapy Market Size by Type (2019-2024)
6.3 APAC Oncology Immunotherapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Immunotherapy by Country (2019-2024)
7.2 Europe Oncology Immunotherapy Market Size by Type (2019-2024)
7.3 Europe Oncology Immunotherapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Immunotherapy by Region (2019-2024)
8.2 Middle East & Africa Oncology Immunotherapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Oncology Immunotherapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY IMMUNOTHERAPY MARKET FORECAST
10.1 Global Oncology Immunotherapy Forecast by Regions (2025-2030)
10.1.1 Global Oncology Immunotherapy Forecast by Regions (2025-2030)
10.1.2 Americas Oncology Immunotherapy Forecast
10.1.3 APAC Oncology Immunotherapy Forecast
10.1.4 Europe Oncology Immunotherapy Forecast
10.1.5 Middle East & Africa Oncology Immunotherapy Forecast
10.2 Americas Oncology Immunotherapy Forecast by Country (2025-2030)
10.2.1 United States Oncology Immunotherapy Market Forecast
10.2.2 Canada Oncology Immunotherapy Market Forecast
10.2.3 Mexico Oncology Immunotherapy Market Forecast
10.2.4 Brazil Oncology Immunotherapy Market Forecast
10.3 APAC Oncology Immunotherapy Forecast by Region (2025-2030)
10.3.1 China Oncology Immunotherapy Market Forecast
10.3.2 Japan Oncology Immunotherapy Market Forecast
10.3.3 Korea Oncology Immunotherapy Market Forecast
10.3.4 Southeast Asia Oncology Immunotherapy Market Forecast
10.3.5 India Oncology Immunotherapy Market Forecast
10.3.6 Australia Oncology Immunotherapy Market Forecast
10.4 Europe Oncology Immunotherapy Forecast by Country (2025-2030)
10.4.1 Germany Oncology Immunotherapy Market Forecast
10.4.2 France Oncology Immunotherapy Market Forecast
10.4.3 UK Oncology Immunotherapy Market Forecast
10.4.4 Italy Oncology Immunotherapy Market Forecast
10.4.5 Russia Oncology Immunotherapy Market Forecast
10.5 Middle East & Africa Oncology Immunotherapy Forecast by Region (2025-2030)
10.5.1 Egypt Oncology Immunotherapy Market Forecast
10.5.2 South Africa Oncology Immunotherapy Market Forecast
10.5.3 Israel Oncology Immunotherapy Market Forecast
10.5.4 Turkey Oncology Immunotherapy Market Forecast
10.5.5 GCC Countries Oncology Immunotherapy Market Forecast
10.6 Global Oncology Immunotherapy Forecast by Type (2025-2030)
10.7 Global Oncology Immunotherapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Oncology Immunotherapy Product Offered
11.1.3 Bristol-Myers Squibb Oncology Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Oncology Immunotherapy Product Offered
11.2.3 Merck & Co Oncology Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck & Co Main Business Overview
11.2.5 Merck & Co Latest Developments
11.3 Roche AG
11.3.1 Roche AG Company Information
11.3.2 Roche AG Oncology Immunotherapy Product Offered
11.3.3 Roche AG Oncology Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche AG Main Business Overview
11.3.5 Roche AG Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Oncology Immunotherapy Product Offered
11.4.3 AstraZeneca Oncology Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Information
11.5.2 Sanofi S.A. Oncology Immunotherapy Product Offered
11.5.3 Sanofi S.A. Oncology Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sanofi S.A. Main Business Overview
11.5.5 Sanofi S.A. Latest Developments
11.6 Dendreon Pharmaceuticals
11.6.1 Dendreon Pharmaceuticals Company Information
11.6.2 Dendreon Pharmaceuticals Oncology Immunotherapy Product Offered
11.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Dendreon Pharmaceuticals Main Business Overview
11.6.5 Dendreon Pharmaceuticals Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Oncology Immunotherapy Product Offered
11.7.3 Novartis Oncology Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Information
11.8.2 Gilead Sciences Inc. Oncology Immunotherapy Product Offered
11.8.3 Gilead Sciences Inc. Oncology Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Gilead Sciences Inc. Main Business Overview
11.8.5 Gilead Sciences Inc. Latest Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA Oncology Immunotherapy Product Offered
11.9.3 Merck KGaA Oncology Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Merck KGaA Main Business Overview
11.9.5 Merck KGaA Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncology Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Immune Checkpoint Inhibitors
Table 3. Major Players of Cytokine-Based Immunotherapy
Table 4. Major Players of Cancer Vaccines
Table 5. Major Players of CAR-T Cell Therapy
Table 6. Major Players of Other
Table 7. Oncology Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 10. Oncology Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 13. Global Oncology Immunotherapy Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Oncology Immunotherapy Revenue Market Share by Player (2019-2024)
Table 15. Oncology Immunotherapy Key Players Head office and Products Offered
Table 16. Oncology Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Immunotherapy Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Oncology Immunotherapy Market Size Market Share by Regions (2019-2024)
Table 21. Global Oncology Immunotherapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Oncology Immunotherapy Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Oncology Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Oncology Immunotherapy Market Size Market Share by Country (2019-2024)
Table 25. Americas Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 27. Americas Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 29. APAC Oncology Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Oncology Immunotherapy Market Size Market Share by Region (2019-2024)
Table 31. APAC Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 33. APAC Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 35. Europe Oncology Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Oncology Immunotherapy Market Size Market Share by Country (2019-2024)
Table 37. Europe Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 39. Europe Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Oncology Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Oncology Immunotherapy
Table 48. Key Market Challenges & Risks of Oncology Immunotherapy
Table 49. Key Industry Trends of Oncology Immunotherapy
Table 50. Global Oncology Immunotherapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Oncology Immunotherapy Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Oncology Immunotherapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Oncology Immunotherapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Bristol-Myers Squibb Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 55. Bristol-Myers Squibb Oncology Immunotherapy Product Offered
Table 56. Bristol-Myers Squibb Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Bristol-Myers Squibb Main Business
Table 58. Bristol-Myers Squibb Latest Developments
Table 59. Merck & Co Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 60. Merck & Co Oncology Immunotherapy Product Offered
Table 61. Merck & Co Main Business
Table 62. Merck & Co Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Merck & Co Latest Developments
Table 64. Roche AG Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 65. Roche AG Oncology Immunotherapy Product Offered
Table 66. Roche AG Main Business
Table 67. Roche AG Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Roche AG Latest Developments
Table 69. AstraZeneca Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 70. AstraZeneca Oncology Immunotherapy Product Offered
Table 71. AstraZeneca Main Business
Table 72. AstraZeneca Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. AstraZeneca Latest Developments
Table 74. Sanofi S.A. Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 75. Sanofi S.A. Oncology Immunotherapy Product Offered
Table 76. Sanofi S.A. Main Business
Table 77. Sanofi S.A. Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Sanofi S.A. Latest Developments
Table 79. Dendreon Pharmaceuticals Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 80. Dendreon Pharmaceuticals Oncology Immunotherapy Product Offered
Table 81. Dendreon Pharmaceuticals Main Business
Table 82. Dendreon Pharmaceuticals Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Dendreon Pharmaceuticals Latest Developments
Table 84. Novartis Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 85. Novartis Oncology Immunotherapy Product Offered
Table 86. Novartis Main Business
Table 87. Novartis Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Novartis Latest Developments
Table 89. Gilead Sciences Inc. Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 90. Gilead Sciences Inc. Oncology Immunotherapy Product Offered
Table 91. Gilead Sciences Inc. Main Business
Table 92. Gilead Sciences Inc. Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Gilead Sciences Inc. Latest Developments
Table 94. Merck KGaA Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 95. Merck KGaA Oncology Immunotherapy Product Offered
Table 96. Merck KGaA Main Business
Table 97. Merck KGaA Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Merck KGaA Latest Developments
Table 1. Oncology Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Immune Checkpoint Inhibitors
Table 3. Major Players of Cytokine-Based Immunotherapy
Table 4. Major Players of Cancer Vaccines
Table 5. Major Players of CAR-T Cell Therapy
Table 6. Major Players of Other
Table 7. Oncology Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 10. Oncology Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 13. Global Oncology Immunotherapy Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Oncology Immunotherapy Revenue Market Share by Player (2019-2024)
Table 15. Oncology Immunotherapy Key Players Head office and Products Offered
Table 16. Oncology Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Immunotherapy Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Oncology Immunotherapy Market Size Market Share by Regions (2019-2024)
Table 21. Global Oncology Immunotherapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Oncology Immunotherapy Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Oncology Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Oncology Immunotherapy Market Size Market Share by Country (2019-2024)
Table 25. Americas Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 27. Americas Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 29. APAC Oncology Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Oncology Immunotherapy Market Size Market Share by Region (2019-2024)
Table 31. APAC Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 33. APAC Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 35. Europe Oncology Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Oncology Immunotherapy Market Size Market Share by Country (2019-2024)
Table 37. Europe Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 39. Europe Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Oncology Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Oncology Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Oncology Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Oncology Immunotherapy
Table 48. Key Market Challenges & Risks of Oncology Immunotherapy
Table 49. Key Industry Trends of Oncology Immunotherapy
Table 50. Global Oncology Immunotherapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Oncology Immunotherapy Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Oncology Immunotherapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Oncology Immunotherapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Bristol-Myers Squibb Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 55. Bristol-Myers Squibb Oncology Immunotherapy Product Offered
Table 56. Bristol-Myers Squibb Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Bristol-Myers Squibb Main Business
Table 58. Bristol-Myers Squibb Latest Developments
Table 59. Merck & Co Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 60. Merck & Co Oncology Immunotherapy Product Offered
Table 61. Merck & Co Main Business
Table 62. Merck & Co Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Merck & Co Latest Developments
Table 64. Roche AG Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 65. Roche AG Oncology Immunotherapy Product Offered
Table 66. Roche AG Main Business
Table 67. Roche AG Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Roche AG Latest Developments
Table 69. AstraZeneca Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 70. AstraZeneca Oncology Immunotherapy Product Offered
Table 71. AstraZeneca Main Business
Table 72. AstraZeneca Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. AstraZeneca Latest Developments
Table 74. Sanofi S.A. Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 75. Sanofi S.A. Oncology Immunotherapy Product Offered
Table 76. Sanofi S.A. Main Business
Table 77. Sanofi S.A. Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Sanofi S.A. Latest Developments
Table 79. Dendreon Pharmaceuticals Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 80. Dendreon Pharmaceuticals Oncology Immunotherapy Product Offered
Table 81. Dendreon Pharmaceuticals Main Business
Table 82. Dendreon Pharmaceuticals Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Dendreon Pharmaceuticals Latest Developments
Table 84. Novartis Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 85. Novartis Oncology Immunotherapy Product Offered
Table 86. Novartis Main Business
Table 87. Novartis Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Novartis Latest Developments
Table 89. Gilead Sciences Inc. Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 90. Gilead Sciences Inc. Oncology Immunotherapy Product Offered
Table 91. Gilead Sciences Inc. Main Business
Table 92. Gilead Sciences Inc. Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Gilead Sciences Inc. Latest Developments
Table 94. Merck KGaA Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 95. Merck KGaA Oncology Immunotherapy Product Offered
Table 96. Merck KGaA Main Business
Table 97. Merck KGaA Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Merck KGaA Latest Developments
LIST OF FIGURES
Figure 1. Oncology Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Immunotherapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oncology Immunotherapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oncology Immunotherapy Sales Market Share by Country/Region (2023)
Figure 8. Oncology Immunotherapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oncology Immunotherapy Market Size Market Share by Type in 2023
Figure 10. Oncology Immunotherapy in Hospitals
Figure 11. Global Oncology Immunotherapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Oncology Immunotherapy in Drugstores
Figure 13. Global Oncology Immunotherapy Market: Drugstores (2019-2024) & ($ Millions)
Figure 14. Oncology Immunotherapy in Others
Figure 15. Global Oncology Immunotherapy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Oncology Immunotherapy Market Size Market Share by Application in 2023
Figure 17. Global Oncology Immunotherapy Revenue Market Share by Player in 2023
Figure 18. Global Oncology Immunotherapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Oncology Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Oncology Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Oncology Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Oncology Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Oncology Immunotherapy Value Market Share by Country in 2023
Figure 24. United States Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Oncology Immunotherapy Market Size Market Share by Region in 2023
Figure 29. APAC Oncology Immunotherapy Market Size Market Share by Type in 2023
Figure 30. APAC Oncology Immunotherapy Market Size Market Share by Application in 2023
Figure 31. China Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Oncology Immunotherapy Market Size Market Share by Country in 2023
Figure 38. Europe Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 61. China Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 65. India Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 68. France Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Oncology Immunotherapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Oncology Immunotherapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Oncology Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Immunotherapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oncology Immunotherapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oncology Immunotherapy Sales Market Share by Country/Region (2023)
Figure 8. Oncology Immunotherapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oncology Immunotherapy Market Size Market Share by Type in 2023
Figure 10. Oncology Immunotherapy in Hospitals
Figure 11. Global Oncology Immunotherapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Oncology Immunotherapy in Drugstores
Figure 13. Global Oncology Immunotherapy Market: Drugstores (2019-2024) & ($ Millions)
Figure 14. Oncology Immunotherapy in Others
Figure 15. Global Oncology Immunotherapy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Oncology Immunotherapy Market Size Market Share by Application in 2023
Figure 17. Global Oncology Immunotherapy Revenue Market Share by Player in 2023
Figure 18. Global Oncology Immunotherapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Oncology Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Oncology Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Oncology Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Oncology Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Oncology Immunotherapy Value Market Share by Country in 2023
Figure 24. United States Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Oncology Immunotherapy Market Size Market Share by Region in 2023
Figure 29. APAC Oncology Immunotherapy Market Size Market Share by Type in 2023
Figure 30. APAC Oncology Immunotherapy Market Size Market Share by Application in 2023
Figure 31. China Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Oncology Immunotherapy Market Size Market Share by Country in 2023
Figure 38. Europe Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Oncology Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 61. China Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 65. India Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 68. France Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Oncology Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Oncology Immunotherapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Oncology Immunotherapy Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Gastroesophageal pH Meter Market Growth 2023-2029
US$ 3,660.00
February 2023
109 pages
Global Dental Prosthetic Material Market Growth 2024-2030
US$ 3,660.00
September 2024
89 pages
Global Etilefrine Hydrochloride Market Growth 2023-2029
US$ 3,660.00
March 2023
98 pages
Global ENT Mouth Gags Market Growth 2024-2030
US$ 3,660.00
September 2024
119 pages
Global Nattokinase Supplements Market Growth 2023-2029
US$ 3,660.00
March 2023
109 pages
